We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Teck Resources
TECK
$32.4B
| $1.34M | ﹤0.01% |
43,910
+650
| +2% | +$20.1K |
|
1027
Comtech Telecommunications
CMTL
$45.8M
| $1.33M | ﹤0.01% |
133,074
+100,039
| +303% | +$1.1M |
|
1028
Workhorse Group
WKHS
$34.1M
| $1.33M | ﹤0.01% |
154
+17
| +12% | +$165K |
|
1029
Jazz Pharmaceuticals
JAZZ
$15.9B
| $1.32M | ﹤0.01% |
9,905
-729
| -7% | -$111K |
|
1030
Universal Logistics Holdings
ULH
$491M
| $1.32M | ﹤0.01% |
41,599
+592
| +1% | +$19.5K |
|
1031
Caesars Entertainment
CZR
$6.05B
| $1.32M | ﹤0.01% |
40,814
+38,687
| +1,819% | +$1.68M |
|
1032
Beyond Meat
BYND
$202M
| $1.32M | ﹤0.01% |
3,095
+2,947
| +1,991% | +$2.44M |
|
|
AIRC
1033
DELISTED
Apartment Income REIT Corp.
AIRC
| $1.31M | ﹤0.01% |
33,997
+3,148
| +10% | +$133K |
|
1034
Ameriprise Financial
AMP
$48.2B
| $1.31M | ﹤0.01% |
5,196
+1,506
| +41% | +$396K |
|
|
DCH
1035
Dauch Corp
DCH
$1.49B
| $1.31M | ﹤0.01% |
191,341
-139,786
| -42% | -$1.26M |
|
1036
Northrop Grumman
NOC
$73.9B
| $1.3M | ﹤0.01% |
2,768
-768
| -22% | -$366K |
|
1037
HF Sinclair
DINO
$20.4B
| $1.3M | ﹤0.01% |
24,116
+1,715
| +8% | +$84.8K |
|
1038
Intel
INTC
$583B
| $1.29M | ﹤0.01% |
50,014
-21,562
| -30% | -$735K |
|
1039
SelectQuote
SLQT
$87M
| $1.29M | ﹤0.01% |
1,763,884
+7,923
| +0.5% | +$13.2K |
|
1040
JELD-WEN Holding
JELD
$167M
| $1.29M | ﹤0.01% |
146,943
+146,439
| +29,055% | +$1.92M |
|
1041
Jones Lang LaSalle
JLL
$15.7B
| $1.28M | ﹤0.01% |
8,483
-728
| -8% | -$127K |
|
1042
Williams-Sonoma
WSM
$26B
| $1.28M | ﹤0.01% |
21,724
-2,654
| -11% | -$188K |
|
1043
Astronics
ATRO
$2.75B
| $1.28M | ﹤0.01% |
195,318
-156,210
| -44% | -$1.3M |
|
1044
J.M. Smucker
SJM
$13.2B
| $1.27M | ﹤0.01% |
9,271
+2,186
| +31% | +$298K |
|
1045
Five Below
FIVE
$13B
| $1.27M | ﹤0.01% |
9,206
-642
| -7% | -$84.3K |
|
1046
T. Rowe Price
TROW
$21.9B
| $1.26M | ﹤0.01% |
12,033
-381,665
| -97% | -$45.5M |
|
1047
Cardlytics
CDLX
$23.1M
| $1.26M | ﹤0.01% |
13,399
+13,306
| +14,308% | +$1.89M |
|
1048
Annaly Capital Management
NLY
$16.1B
| $1.25M | ﹤0.01% |
73,014
+70,861
| +3,291% | +$1.79M |
|
1049
Chemours
CC
$2.2B
| $1.25M | ﹤0.01% |
50,709
-93,634
| -65% | -$3.09M |
|
1050
Lockheed Martin
LMT
$122B
| $1.24M | ﹤0.01% |
3,218
-16,009
| -83% | -$6.68M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.